Saratoga Investment Corp.
SARATOGA INVESTMENT CORP. (Form: 10-Q, Received: 01/11/2017 16:01:52)
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended November 30, 2016

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 001-33376

 

 

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   20-8700615

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

535 Madison Avenue

New York, New York

  10022
(Address of principal executive office)   (Zip Code)

(212) 906-7800

(Registrant’s telephone number, including area code)

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☐    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

 

Large Accelerated Filer      Accelerated Filer  
Non-Accelerated Filer      Smaller Reporting Company  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of January 10, 2017 was 5,744,147.

 

 

 


Table of Contents

TABLE OF CONTENTS

 

 

 

         Page  

PART I.

  FINANCIAL INFORMATION      3   
Item 1.   Consolidated Financial Statements      3   
  Consolidated Statements of Assets and Liabilities as of November 30, 2016 (unaudited) and February 29, 2016      3   
  Consolidated Statements of Operations for the three and nine months ended November 30, 2016 and November 30, 2015 (unaudited)      4   
  Consolidated Schedules of Investments as of November 30, 2016 (unaudited) and February 29, 2016      5   
  Consolidated Statements of Changes in Net Assets for the nine months ended November 30, 2016 and November 30, 2015 (unaudited)      7   
  Consolidated Statements of Cash Flows for the nine months ended November 30, 2016 and November 30, 2015 (unaudited)      8   
  Notes to Consolidated Financial Statements as of November 30, 2016 (unaudited)      9   
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations      35   
Item 3.   Quantitative and Qualitative Disclosures About Market Risk      58   
Item 4.   Controls and Procedures      58   
PART II.   OTHER INFORMATION      59   
Item 1.   Legal Proceedings      59   
Item 1A.   Risk Factors      59   
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds      59   
Item 3.   Defaults Upon Senior Securities      59   
Item 4.   Mine Safety Disclosures      59   
Item 5.   Other Information      59   
Item 6.   Exhibits      60   
Signatures      61   

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

     As of  
     November 30, 2016     February 29, 2016  
     (unaudited)        

ASSETS

    

Investments at fair value

    

Non-control/Non-affiliate investments (amortized cost of $270,029,200 and $268,145,090, respectively)

   $   262,303,777      $   271,168,186   

Control investments (cost of $15,448,369 and $13,030,751, respectively)

     15,265,995        12,827,980   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $285,477,569 and $281,175,841, respectively)

     277,569,772        283,996,166   

Cash and cash equivalents

     5,770,230        2,440,277   

Cash and cash equivalents, reserve accounts

     17,521,282        4,594,506   

Interest receivable (net of reserve of $0 and $728,519, respectively)

     3,984,752        3,195,919   

Due from affiliate

     46,078        —     

Management fee receivable

     170,975        170,016   

Other assets

     184,761        350,368   

Receivable from unsettled trades

     284,903        300,000   
  

 

 

   

 

 

 

Total assets

   $ 305,532,753      $ 295,047,252   
  

 

 

   

 

 

 

LIABILITIES

    

Revolving credit facility

   $ —        $ —     

Deferred debt financing costs, revolving credit facility

     (456,594     (515,906

SBA debentures payable

     112,660,000        103,660,000   

Deferred debt financing costs, SBA debentures payable

     (2,622,206     (2,493,303

Notes payable

     61,793,125        61,793,125   

Deferred debt financing costs, notes payable

     (1,553,545     (1,694,586

Dividend payable

     —          875,599   

Base management and incentive fees payable

     5,932,447        5,593,956   

Accounts payable and accrued expenses

     672,791        855,873   

Interest and debt fees payable

     1,098,309        1,552,069   

Payable for repurchases of common stock

     —          20,957   

Directors fees payable

     51,000        31,500   

Due to manager

     277,696        218,093   
  

 

 

   

 

 

 

Total liabilities

   $ 177,853,023      $ 169,897,377   
  

 

 

   

 

 

 

Commitments and contingencies (See Note 7)

    

NET ASSETS

    

Common stock, par value $.001, 100,000,000 common shares authorized, 5,748,247 and 5,672,227 common shares issued and outstanding, respectively

   $ 5,748      $ 5,672   

Capital in excess of par value

     189,583,336        188,714,329   

Distribution in excess of net investment income

     (26,128,907     (26,217,902

Accumulated net realized loss from investments and derivatives

     (27,872,650     (40,172,549

Accumulated net unrealized appreciation (depreciation) on investments and derivatives

     (7,907,797     2,820,325   
  

 

 

   

 

 

 

Total net assets

     127,679,730        125,149,875   
  

 

 

   

 

 

 

Total liabilities and net assets

   $ 305,532,753      $ 295,047,252   
  

 

 

   

 

 

 

NET ASSET VALUE PER SHARE

   $ 22.21      $ 22.06   
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

 

     For the three months ended
November 30
     For the nine months ended
November 30
 
     2016     2015      2016     2015  

INVESTMENT INCOME

         

Interest from investments

         

Non-control/Non-affiliate investments

   $ 6,787,898      $ 5,435,083       $ 19,969,849      $ 16,961,744   

Payment-in-kind interest income from Non-control/Non-affiliate investments

     169,332        41,322         482,687        995,465   

Control investments

     498,599        750,605         1,587,925        2,020,301   
  

 

 

   

 

 

    

 

 

   

 

 

 

Total interest income

     7,455,829        6,227,010         22,040,461        19,977,510   

Interest from cash and cash equivalents

     6,239        1,307         16,426        2,774   

Management fee income

     375,218        369,388         1,123,559        1,121,286   

Other income

     605,009        338,219         1,618,238        1,153,838   
  

 

 

   

 

 

    

 

 

   

 

 

 

Total investment income

     8,442,295        6,935,924         24,798,684        22,255,408   
  

 

 

   

 

 

    

 

 

   

 

 

 

EXPENSES

         

Interest and debt financing expenses

     2,369,108        2,129,105         7,106,869        6,240,946   

Base management fees

     1,219,916        1,091,405         3,649,867        3,366,739   

Professional fees

     330,197        347,639         991,723        1,030,616   

Administrator expenses

     341,667        325,000         991,667        850,000   

Incentive management fees

     394,509        404,218         2,331,241        2,160,772   

Insurance

     68,985        85,262         210,301        259,895   

Directors fees and expenses

     66,000        51,000         192,422        153,000   

General & administrative

     224,579        351,875         741,743        738,244   

Excise tax expense (credit)

     —          —           —          (123,338

Other expense

     8,460        —           21,647        —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Total expenses

     5,023,421        4,785,504         16,237,480        14,676,874   
  

 

 

   

 

 

    

 

 

   

 

 

 

NET INVESTMENT INCOME

     3,418,874        2,150,420         8,561,204        7,578,534   
  

 

 

   

 

 

    

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

         

Net realized gain from investments

     260,244        447,813         12,299,899        4,231,006   

Net unrealized appreciation (depreciation) on investments

     (2,105,342     823,093         (10,728,122     239,354   
  

 

 

   

 

 

    

 

 

   

 

 

 

Net gain (loss) on investments

     (1,845,098     1,270,906         1,571,777        4,470,360   
  

 

 

   

 

 

    

 

 

   

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

   $ 1,573,776      $ 3,421,326       $ 10,132,981      $ 12,048,894   
  

 

 

   

 

 

    

 

 

   

 

 

 

WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS PER COMMON SHARE

   $ 0.27      $ 0.61       $ 1.77      $ 2.18   

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED

     5,727,933        5,632,011         5,735,443        5,533,094   

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2016

(unaudited)

 

Company

 

Industry

 

Investment Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Non-control/Non-affiliated investments - 205.4% (b)

       

CAMP International Systems (d)

  Aerospace and Defense   Second Lien Term Loan (L+7.25%), 8.25% Cash, 8/18/2024   $ 1,000,000      $ 995,171      $ 1,020,000        0.8
       

 

 

   

 

 

   

 

 

 
    Total Aerospace and Defense       995,171        1,020,000        0.8
       

 

 

   

 

 

   

 

 

 

Polar Holding Company, Ltd. (a), (d), (i)

  Building Products   First Lien Term Loan (L+9.00%), 10.00% Cash, 9/30/2016   $ 2,000,000        2,000,000        2,000,000        1.6
       

 

 

   

 

 

   

 

 

 
    Total Building Products       2,000,000        2,000,000        1.6
       

 

 

   

 

 

   

 

 

 

Apex Holdings Software Technologies, LLC

  Business Services   First Lien Term Loan (L+8.00%), 9.00% Cash, 9/21/2021   $ 18,000,000        17,848,031        17,842,500        14.0

Avionte Holdings, LLC (g)

  Business Services   Common Stock     100,000        100,000        251,000        0.2

Avionte Holdings, LLC

  Business Services   First Lien Term Loan (L+8.25%), 9.75% Cash, 1/8/2019   $ 2,279,278        2,257,229        2,279,278        1.8

Avionte Holdings, LLC (j), (k)

  Business Services   Delayed Draw Term Loan A (L+8.25%), 9.75% Cash, 1/8/2019   $ —          —          —          0.0

BMC Software, Inc. (d)

  Business Services   First Lien Term Loan (L+4.00%), 5.00% Cash, 9/10/2020   $ 5,626,667        5,594,987        5,493,315        4.3

Courion Corporation

  Business Services   Second Lien Term Loan (L+10.00%), 11.00% Cash, 6/1/2021   $ 15,000,000        14,872,231        13,932,000        10.9

Dispensing Dynamics International (d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018   $ 12,000,000        12,015,235        11,640,000        9.1

Easy Ice, LLC (d)

  Business Services   First Lien Term Loan (L+8.75%), 9.50% Cash, 1/15/2020   $ 16,000,000        15,876,901        16,080,000        12.6

Emily Street Enterprises, L.L.C.

  Business Services   Senior Secured Note (L+8.50%), 10.00% Cash, 1/23/2020   $ 3,300,000        3,277,195        3,318,810        2.6

Emily Street Enterprises, L.L.C. (g)

  Business Services   Warrant Membership Interests, Expires 12/28/2022     49,318        400,000        476,541        0.3

Erwin, Inc.

  Business Services   Second Lien Term Loan (L+11.50%), 13.50% (11.50% Cash/1.00% PIK), 8/28/2021   $ 13,077,419        12,957,650        13,077,419        10.2

GreyHeller LLC

  Business Services   First Lien Term Loan (L+11.00%), 12.00% Cash, 11/16/2021   $ 7,000,000        6,930,320        6,930,000        5.4

GreyHeller LLC (j), (k)

  Business Services   Delayed Draw Term Loan B (L+11.00%), 12.00% Cash, 11/16/2021   $ —          —          —          0.0

GreyHeller LLC (g)

  Business Services   Common Stock     850,000        850,000        850,000        0.7

Help/Systems Holdings, Inc.(Help/Systems, LLC)

  Business Services   First Lien Term Loan (L+5.25%), 6.25% Cash, 10/8/2021   $ 4,962,500        4,878,301        4,921,311        3.9

Help/Systems Holdings, Inc.(Help/Systems, LLC)

  Business Services   Second Lien Term Loan (L+9.50%), 10.50% Cash, 10/8/2022   $ 3,000,000        2,919,579        2,820,000        2.2

Identity Automation Systems

  Business Services   Convertible Promissory Note 13.50% (6.75% Cash/6.75% PIK), 8/18/2018     611,517        611,521        611,521        0.5

Identity Automation Systems (g)

  Business Services   Common Stock Class A Units     232,616        232,616        549,258        0.4

Identity Automation Systems

  Business Services   First Lien Term Loan (L+9.25%), 12.00% (9.25% Cash/1.75% PIK) 12/18/2020   $ 10,248,887        10,172,877        10,248,887        8.0

Knowland Technology Holdings, L.L.C.

  Business Services   First Lien Term Loan (L+8.75%), 9.75% Cash, 11/29/2017   $ 17,777,730        17,664,387        17,777,730        13.9

Microsystems Company

  Business Services   Second Lien Term Loan (L+10.00%), 11.00% Cash, 7/1/2022   $ 8,000,000        7,924,524        7,920,000        6.2

Vector Controls Holding Co., LLC (d)

  Business Services   First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 8,877,910        8,826,316        8,877,910        7.0

Vector Controls Holding Co., LLC (d), (g)

  Business Services   Warrants to Purchase Limited Liability Company Interests, Expires 5/31/2025     343        —          352,260        0.3
       

 

 

   

 

 

   

 

 

 
    Total Business Services       146,209,900        146,249,740        114.5
       

 

 

   

 

 

   

 

 

 

Targus Holdings, Inc. (d), (g)

  Consumer Products   Common Stock     210,456        1,791,242        —          0.0

Targus Holdings, Inc. (d)

  Consumer Products   Second Lien Term Loan A-2 15.00% PIK, 12/31/2019   $ 228,909        228,909        228,909        0.2

Targus Holdings, Inc. (d)

  Consumer Products   Second Lien Term Loan B 15.00% PIK, 12/31/2019   $ 686,726        686,726        558,171        0.4
       

 

 

   

 

 

   

 

 

 
    Total Consumer Products       2,706,877        787,080        0.6
       

 

 

   

 

 

   

 

 

 

My Alarm Center, LLC

  Consumer Services   Second Lien Term Loan (L+11.00%), 12.00% Cash, 7/9/2019   $ 9,375,000        9,357,973        9,345,938        7.3

PrePaid Legal Services, Inc. (d)

  Consumer Services   First Lien Term Loan (L+5.25%), 6.50% Cash, 7/1/2019   $ 1,488,754        1,483,515        1,487,266        1.1

PrePaid Legal Services, Inc. (d)

  Consumer Services   Second Lien Term Loan (L+9.25%), 10.25% Cash, 7/1/2020   $ 10,000,000        9,968,634        9,904,000        7.8
       

 

 

   

 

 

   

 

 

 
    Total Consumer Services       20,810,122        20,737,204        16.2
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C. (d)

  Education   First Lien Term Loan 1.00% Cash, 3/31/2018   $ 2,321,073        1,193,790        8,087        0.0

Teachers of Tomorrow, LLC (g), (h)

  Education   Common Stock     750        750,000        910,545        0.8

Teachers of Tomorrow, LLC

  Education   Second Lien Term Loan (L+9.75%), 10.75% Cash, 6/2/2021   $ 10,000,000        9,914,485        10,000,000        7.8
       

 

 

   

 

 

   

 

 

 
    Total Education       11,888,516        10,918,632        8.6
       

 

 

   

 

 

   

 

 

 

TM Restaurant Group L.L.C.

  Food and Beverage   First Lien Term Loan (L+8.50%), 9.75% Cash, 7/16/2017   $ 9,358,694        9,313,879        8,422,825        6.6
       

 

 

   

 

 

   

 

 

 
    Total Food and Beverage       9,313,879        8,422,825        6.6
       

 

 

   

 

 

   

 

 

 

Censis Technologies, Inc.

  Healthcare Services   First Lien Term Loan B (L+10.00%), 11.00% Cash, 7/24/2019   $ 11,250,000        11,114,850        10,871,661        8.4

Censis Technologies, Inc. (g), (h)

  Healthcare Services   Limited Partner Interests     999        999,000        725,936        0.6

Roscoe Medical, Inc. (d), (g)

  Healthcare Services   Common Stock     5,081        508,077        678,931        0.5

Roscoe Medical, Inc.

  Healthcare Services   Second Lien Term Loan 11.25% Cash, 9/26/2019   $ 4,200,000        4,151,963        4,154,220        3.3

Ohio Medical, LLC (g)

  Healthcare Services   Common Stock     5,000        500,000        329,096        0.3

Ohio Medical, LLC

  Healthcare Services   Senior Subordinated Note 12.00%, 7/15/2021   $ 7,300,000        7,235,173        7,234,300        5.7

Zest Holdings, LLC (d)

  Healthcare Services   First Lien Term Loan (L+4.75%), 5.75% Cash, 8/16/2020   $ 4,136,911        4,081,904        4,134,015        3.2
       

 

 

   

 

 

   

 

 

 
    Total Healthcare Services       28,590,967        28,128,159        22.0
       

 

 

   

 

 

   

 

 

 

HMN Holdco, LLC

  Media   First Lien Term Loan 10.00% Cash, 5/16/2019   $ 8,581,357        8,485,902        8,581,357        6.7

HMN Holdco, LLC

  Media   Delayed Draw First Lien Term Loan 10.00% Cash, 5/16/2019   $ 4,800,000        4,748,026        4,800,000        3.7

HMN Holdco, LLC (g)

  Media   Class A Series, Expires 1/16/2025     4,264        61,647        282,106        0.2

HMN Holdco, LLC (g)

  Media   Class A Warrant, Expires 1/16/2025     30,320        438,353        1,616,966        1.3

HMN Holdco, LLC (g)

  Media   Warrants to Purchase Limited Liability Company Interests (Common), Expires 5/16/2024     57,872        —          2,791,745        2.2

HMN Holdco, LLC (g)

  Media   Warrants to Purchase Limited Liability Company Interests (Preferred), Expires 5/16/2024     8,139        —          449,761        0.4
       

 

 

   

 

 

   

 

 

 
    Total Media       13,733,928        18,521,935        14.5
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company, L.L.C. (d), (g)

  Metals   Common Stock     35,000        9,217,564        357,350        0.3

Elyria Foundry Company, L.L.C. (d)

  Metals   Revolver (L+8.50%), 10.00% Cash, 3/31/2017   $ 8,500,000        8,500,000        8,500,000        6.6
       

 

 

   

 

 

   

 

 

 
    Total Metals       17,717,564        8,857,350        6.9
       

 

 

   

 

 

   

 

 

 

Mercury Network, LLC

  Real Estate   First Lien Term Loan 10.5% Cash, 8/24/2021   $ 15,791,286        15,649,233        15,871,821        12.5

Mercury Network, LLC (g)

  Real Estate   Common Stock     413,043        413,043        789,031        0.6
       

 

 

   

 

 

   

 

 

 
    Total Real Estate       16,062,276        16,660,852        13.1
       

 

 

   

 

 

   

 

 

 

Sub Total Non-control/Non-affiliated investments

      270,029,200        262,303,777        205.4
       

 

 

   

 

 

   

 

 

 

Control investments - 12.0% (b)

           

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

  Structured Finance Securities   Other/Structured Finance Securities 13.26%, 10/17/2025   $ 30,000,000        10,948,369        10,986,945        8.6

Saratoga Investment Corp. Class F
Note (a), (d), (f)

  Structured Finance Securities   Other/Structured Finance Securities (L+8.50%), 9.22%, 10/20/2025   $ 4,500,000        4,500,000        4,279,050        3.4
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          15,448,369        15,265,995        12.0
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS - 217.4% (b)

        $   285,477,569      $   277,569,772        217.4
       

 

 

   

 

 

   

 

 

 
            Principal     Cost     Fair Value     % of
Net Assets
 

Cash and cash equivalents and cash and cash equivalents, reserve accounts - 18.2%

       

U.S. Bank Money Market (l)

      $ 23,291,512      $ 23,291,512      $ 23,291,512        18.2
     

 

 

   

 

 

   

 

 

   

 

 

 

Total cash and cash equivalents and cash and cash equivalents, reserve accounts

  $ 23,291,512      $ 23,291,512      $ 23,291,512        18.2
     

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Represents a non-qualifying investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 6.2% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $127,679,730 as of November 30, 2016.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 13.26% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

                Sales
(Cost)
    Interest
Income
    Management
Fee Income
    Net Realized
Gains
(Losses)
    Net Unrealized  

Company

  Purchases     Redemptions             Appreciation
(Depreciation)
 

Saratoga Investment Corp. CLO
2013-1, Ltd.

  $ —        $ —        $ —        $ 1,569,492      $ 1,123,559      $ —        $ 241,347   

Saratoga Investment Corp. Class F Note

  $ 4,500,000      $ —        $ —        $ 18,433      $ —        $ —        $ (220,950
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(g) Non-income producing at November 30, 2016.
(h) Includes securities issued by an affiliate of the Company.
(i) Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j) The investment has an unfunded commitment as of November 30, 2016 (see Note 7 to the consolidated financial statements).
(k) The entire commitment was unfunded at November 30, 2016. As such, no interest is being earned on this investment.
(l) Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s Consolidated Statements of Assets and Liabilities as of November 30, 2016.

 

5


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2016

 

Company

 

Industry

 

Investment Interest Rate / Maturity

  Principal/
Number

of Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Non-control/Non-affiliated investments - 216.6% (b)

  

     

National Truck Protection Co., Inc. (d), (g)

  Automotive Aftermarket   Common Stock     1,116      $ 1,000,000      $ 1,695,303        1.4

National Truck Protection Co., Inc. (d)

  Automotive Aftermarket   First Lien Term Loan 15.50% Cash, 9/13/2018   $ 6,776,770        6,776,770        6,776,770        5.4

Take 5 Oil Change, L.L.C. (d), (g)

  Automotive Aftermarket   Common Stock     7,128        480,535        6,235,209        5.0
       

 

 

   

 

 

   

 

 

 
    Total Automotive Aftermarket       8,257,305        14,707,282        11.8
       

 

 

   

 

 

   

 

 

 

Legacy Cabinets Holdings (d), (g)

  Building Products   Common Stock Voting A-1     2,535        220,900        2,676,909        2.1

Legacy Cabinets Holdings (d), (g)

  Building Products   Common Stock Voting B-1     1,600        139,424        1,689,568        1.3

Polar Holding Company,
Ltd. (a), (d), (i)

  Building Products   First Lien Term Loan (L+9.00%), 10.00% Cash, 9/30/2016   $ 2,000,000        2,000,000        2,000,000        1.6
       

 

 

   

 

 

   

 

 

 
    Total Building Products       2,360,324        6,366,477        5.0
       

 

 

   

 

 

   

 

 

 

Avionte Holdings, LLC (g)

  Business Services   Common Stock     100,000        100,000        169,850        0.1

Avionte Holdings, LLC

  Business Services   First Lien Term Loan (L+8.25%), 9.75% Cash, 1/8/2019   $ 2,406,342        2,376,045        2,382,844        1.9

Avionte Holdings, LLC (j), (k)

  Business Services   Delayed Draw Term Loan A (L+8.25%), 9.75% Cash, 1/8/2019   $ —          —          —          0.0

BMC Software, Inc. (d)

  Business Services   Syndicated Loan (L+4.00%), 5.00% Cash, 9/10/2020   $ 5,671,667        5,633,920        4,520,318        3.6

Courion Corporation

  Business Services   Second Lien Term Loan (L+10.00%), 11.00% Cash, 6/1/2021   $ 15,000,000        14,856,720        14,850,000        11.9

Dispensing Dynamics
International (d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018   $ 12,000,000        12,025,101        10,950,000        8.8

Easy Ice, LLC (d)

  Business Services   First Lien Term Loan (L+8.75%), 9.50% Cash, 1/15/2020   $ 14,000,000        13,873,485        13,806,098        11.0

Emily Street Enterprises, L.L.C.

  Business Services   Senior Secured Note (L+8.50%), 10.00% Cash, 1/23/2020   $ 8,400,000        8,305,033        8,568,000        6.8

Emily Street Enterprises, L.L.C. (g)

  Business Services   Warrant Membership Interests, Expires 12/28/2022     49,318        400,000        577,020        0.5

Erwin, Inc.

  Business Services   Second Lien Term Loan (L+11.50%), 13.50% (12.50% Cash/1.00% PIK), 8/28/2021   $ 13,000,000        12,870,023        12,870,000        10.3

Finalsite Holdings, Inc.

  Business Services   Second Lien Term Loan (L+9.00%), 10.25% Cash, 5/21/2020   $ 7,500,000        7,440,729        7,500,000        6.0

Help/Systems Holdings, Inc.(Help/Systems, LLC)

  Business Services   First Lien Term Loan (L+5.25%), 6.25% Cash, 10/8/2021   $ 5,000,000        4,904,573        4,895,000        3.9

Help/Systems Holdings, Inc.(Help/Systems, LLC)

  Business Services   Second Lien Term Loan (L+9.50%), 10.50% Cash, 10/8/2022   $ 3,000,000        2,912,784        2,910,000        2.3

Identity Automation Systems (g)

  Business Services   Common Stock Class A Units     232,616        232,616        427,409        0.3

Identity Automation Systems

  Business Services   First Lien Term Loan (L+9.25%), 10.25% Cash, 12/18/2020   $ 6,900,000        6,842,573        6,900,000        5.5

Identity Automation Systems (j), (k)

  Business Services   Delayed Draw Term Loan 10.25% Cash, 12/18/2020   $ —          —          —          0.0

Knowland Technology Holdings, L.L.C.

  Business Services   First Lien Term Loan 8.00% Cash, 11/29/2017   $ 5,259,171        5,224,422        5,259,171        4.2

Vector Controls Holding Co.,
LLC (d)

  Business Services   First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 9,035,515        8,952,442        9,035,515        7.2

Vector Controls Holding Co.,
LLC (d), (g)

  Business Services   Warrants to Purchase Limited Liability Company Interests, Expires 5/31/2025     343        —          354,819        0.3
       

 

 

   

 

 

   

 

 

 
    Total Business Services       106,950,466        105,976,044        84.6
       

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Consumer Products   First Lien Term Loan 9.50% Cash, 7/17/2020   $ 6,800,000        6,733,661        6,800,000        5.4

Targus Holdings, Inc. (d), (g)

  Consumer Products   Common Stock     210,456        1,791,242        —          0.0

Targus Holdings, Inc. (d)

  Consumer Products   Second Lien Term Loan A-2 15.00% PIK, 12/31/2019   $ 210,456        210,456        210,456        0.2

Targus Holdings, Inc. (d)

  Consumer Products   Second Lien Term Loan B 15.00% PIK, 12/31/2019   $ 631,369        631,369        631,369        0.5
       

 

 

   

 

 

   

 

 

 
    Total Consumer Products       9,366,728        7,641,825        6.1
       

 

 

   

 

 

   

 

 

 

Expedited Travel L.L.C. (g)

  Consumer Services   Common Stock     1,000,000        1,000,000        1,647,767        1.3

Expedited Travel L.L.C.

  Consumer Services   First Lien Term Loan 10.00% Cash, 10/10/2019   $ 11,475,490        11,401,380        11,647,623        9.3

My Alarm Center, LLC

  Consumer Services   Second Lien Term Loan (L+11.00%), 12.00% Cash, 7/9/2019   $ 7,500,000        7,500,000        7,450,500        6.0

PrePaid Legal Services, Inc. (d)

  Consumer Services   First Lien Term Loan (L+5.25%), 6.50% Cash, 7/1/2019   $ 1,572,921        1,562,787        1,556,248        1.2

PrePaid Legal Services, Inc. (d)

  Consumer Services   Second Lien Term Loan (L+9.00%), 10.25% Cash, 7/1/2020   $ 10,000,000        9,962,104        9,827,000        7.9

Prime Security Services, LLC

  Consumer Services   Second Lien Term Loan (L+8.75%), 9.75% Cash, 7/1/2022   $ 12,000,000        11,829,030        10,980,000        8.8
       

 

 

   

 

 

   

 

 

 
    Total Consumer Services       43,255,301        43,109,138        34.5
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C. (d)

  Education   First Lien Term Loan 1.00% Cash, 3/31/2016   $ 2,321,073        1,193,790        8,087        0.0

Teachers of Tomorrow, LLC (g), (h)

  Education   Common Stock     750        750,000        785,475        0.6

Teachers of Tomorrow, LLC

  Education   Second Lien Term Loan (L+9.75%), 10.75% Cash, 6/2/2021   $ 10,000,000        9,902,816        9,900,000        7.9
       

 

 

   

 

 

   

 

 

 
    Total Education       11,876,847        10,693,562        8.5
       

 

 

   

 

 

   

 

 

 

TM Restaurant Group L.L.C.

  Food and Beverage   First Lien Term Loan (L+8.50%), 9.75% Cash, 7/16/2017   $ 9,622,319        9,527,041        9,131,048        7.3
       

 

 

   

 

 

   

 

 

 
    Total Food and Beverage       9,527,041        9,131,048        7.3
       

 

 

   

 

 

   

 

 

 

Bristol Hospice, LLC

  Healthcare Services   Senior Secured Note 11.00% (10.00% Cash/1.00% PIK), 11/29/2018   $ 5,404,747        5,339,820        5,404,747        4.3

Censis Technologies, Inc.

  Healthcare Services   First Lien Term Loan B (L+10.00%), 11.00% Cash, 7/24/2019   $ 11,550,000        11,377,810        11,459,418        9.2

Censis Technologies, Inc. (g), (h)

  Healthcare Services   Limited Partner Interests     999        999,000        810,642        0.7

Roscoe Medical, Inc. (d), (g)

  Healthcare Services   Common Stock     5,000        500,000        334,000        0.3

Roscoe Medical, Inc.

  Healthcare Services   Second Lien Term Loan 11.25% Cash, 9/26/2019   $ 4,200,000        4,141,519        3,822,000        3.0

Ohio Medical, LLC (g)

  Healthcare Services   Common Stock     5,000        500,000        500,000        0.4

Ohio Medical, LLC

  Healthcare Services   Senior Subordinated Note 12.00%, 7/15/2021   $ 7,300,000        7,228,452        7,227,000        5.8

Smile Brands Group Inc. (d)

  Healthcare Services   Syndicated Loan (L+7.75%), 10.50% (9.00% Cash/1.50% PIK), 8/16/2019   $ 4,420,900        4,362,266        3,216,647        2.6

Zest Holdings, LLC (d)

  Healthcare Services   Syndicated Loan (L+4.25%), 5.25% Cash, 8/16/2020   $ 4,207,821        4,142,093        4,130,692        3.3
       

 

 

   

 

 

   

 

 

 
    Total Healthcare Services       38,590,960        36,905,146        29.6
       

 

 

   

 

 

   

 

 

 

HMN Holdco, LLC

  Media   First Lien Term Loan 10.00% Cash, 5/16/2019   $ 8,937,982        8,812,479        8,937,983        7.1

HMN Holdco, LLC

  Media   First Lien Term Loan 10.00% Cash, 5/16/2019   $ 1,600,000        1,572,821        1,600,000        1.3

HMN Holdco, LLC (g)

  Media   Class A Series, Expires 1/16/2025     4,264        61,647        314,683        0.3

HMN Holdco, LLC (g)

  Media   Class A Warrant, Expires 1/16/2025     30,320        438,353        1,889,542        1.5

HMN Holdco, LLC (g)

  Media   Warrants to Purchase Limited Liability Company Interests (Common), Expires 5/16/2024     57,872        —          3,309,121        2.6

HMN Holdco, LLC (g)

  Media   Warrants to Purchase Limited Liability Company Interests, Expires 5/16/2024     8,139        —          523,012        0.4
       

 

 

   

 

 

   

 

 

 
    Total Media       10,885,300        16,574,341        13.2
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company,
L.L.C. (d), (g)

  Metals   Common Stock     35,000        9,217,564        2,026,150        1.6

Elyria Foundry Company,
L.L.C. (d)

  Metals   Revolver 10.00% Cash, 3/31/2017   $ 8,500,000        8,500,000        8,500,000        6.8
       

 

 

   

 

 

   

 

 

 
    Total Metals       17,717,564        10,526,150        8.4
       

 

 

   

 

 

   

 

 

 

Mercury Network, LLC

  Real Estate   First Lien Term Loan (L+9.25%), 10.25% Cash, 4/24/2020   $ 9,025,000        8,944,211        9,025,000        7.2

Mercury Network, LLC (g)

  Real Estate   Common Stock     413,043        413,043        512,173        0.4
       

 

 

   

 

 

   

 

 

 
    Total Real Estate       9,357,254        9,537,173        7.6
       

 

 

   

 

 

   

 

 

 

Sub Total Non-control/Non-affiliated investments

      268,145,090        271,168,186        216.6
       

 

 

   

 

 

   

 

 

 

Control investments - 10.3% (b)

         

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

  Structured Finance Securities   Other/Structured Finance Securities 16.14%, 10/17/2023   $ 30,000,000        13,030,751        12,827,980        10.3
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          13,030,751        12,827,980        10.3
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS - 226.9% (b)

    $ 281,175,841      $ 283,996,166        226.9
       

 

 

   

 

 

   

 

 

 
            Principal     Cost     Fair Value     % of
Net Assets
 

Cash and cash equivalents and cash and cash equivalents, reserve accounts - 5.6%

       

U.S. Bank Money Market (l)

      $ 7,034,783      $ 7,034,783      $ 7,034,783        5.6
     

 

 

   

 

 

   

 

 

   

 

 

 

Total cash and cash equivalents and cash and cash equivalents, reserve accounts

  $ 7,034,783      $ 7,034,783      $ 7,034,783        5.6
     

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Represents a non-qualifying investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 5.2% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $125,149,875 as of February 29, 2016.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 16.14% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

                          Interest      Management      Net
Realized
     Net Unrealized  

Company

   Purchases      Redemptions      Sales (Cost)      Income      Fee Income      Gains
(Losses)
     Depreciation  

Saratoga Investment Corp. CLO 2013-1, Ltd.

   $ —         $ —         $ —         $ 2,665,648       $ 1,494,779       $ —         $ (1,280,916
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(g) Non-income producing at February 29, 2016.
(h) Includes securities issued by an affiliate of the Company.
(i) Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j) The investment has an unfunded commitment as of February 29, 2016 (see Note 7 to the consolidated financial statements).
(k) The entire commitment was unfunded at February 29, 2016. As such, no interest is being earned on this investment.
(l) Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s Consolidated Statements of Assets and Liabilities as of February 29, 2016.

 

 

6


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

 

     For the nine months ended
November 30, 2016
    For the nine months ended
November 30, 2015
 

INCREASE FROM OPERATIONS:

    

Net investment income

   $ 8,561,204      $ 7,578,534   

Net realized gain from investments

     12,299,899        4,231,006   

Net unrealized appreciation (depreciation) on investments

     (10,728,122     239,354   
  

 

 

   

 

 

 

Net increase in net assets from operations

     10,132,981        12,048,894   
  

 

 

   

 

 

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

    

Distributions declared

     (8,472,209     (10,767,093
  

 

 

   

 

 

 

Net decrease in net assets from shareholder distributions

     (8,472,209     (10,767,093
  

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS:

    

Stock dividend distribution

     4,125,696        3,778,630   

Repurchases of common stock

     (3,256,613     (38,981

Offering costs

     —          (346,826
  

 

 

   

 

 

 

Net increase in net assets from capital share transactions

     869,083        3,392,823   
  

 

 

   

 

 

 

Total increase in net assets

     2,529,855        4,674,624   

Net assets at beginning of period

     125,149,875        122,598,742   
  

 

 

   

 

 

 

Net assets at end of period

   $ 127,679,730      $ 127,273,366   
  

 

 

   

 

 

 

Net asset value per common share

   $ 22.21      $ 22.59   

Common shares outstanding at end of period

     5,748,247        5,634,115   

Distribution in excess of net investment income

   $ (26,128,907   $ (27,094,304

See accompanying notes to consolidated financial statements.

 

7


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

 

     For the nine months ended
November 30, 2016
    For the nine months ended
November 30, 2015
 

Operating activities

    

NET INCREASE IN NET ASSETS FROM OPERATIONS

   $ 10,132,981      $ 12,048,894   

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH PROVIDED BY OPERATING ACTIVITIES:

    

Payment-in-kind interest income

     (433,609     (900,398

Net accretion of discount on investments

     (408,557     (377,279

Amortization of deferred debt financing costs

     775,707        669,831   

Net realized gain from investments

     (12,299,899     (4,231,006

Net unrealized (appreciation) depreciation on investments

     10,728,122        (239,354

Proceeds from sales and repayments of investments

     94,691,232        62,676,779   

Purchase of investments

     (85,850,895     (57,428,806

(Increase) decrease in operating assets:

    

Interest receivable

     (788,833     (504,339

Due from affiliate

     (46,078     —     

Management fee receivable

     (959     1,657   

Other assets

     106,195        (163,557

Receivable from unsettled trades

     15,097        —     

Increase (decrease) in operating liabilities:

    

Base management and incentive fees payable

     338,491        (178,074

Accounts payable and accrued expenses

     (183,082     (176,414

Interest and debt fees payable

     (453,760     (555,104

Payable for repurchases of common stock

     (20,957     —     

Directors fees payable

     19,500        (10,500

Due to manager

     59,603        (3,958
  

 

 

   

 

 

 

NET CASH PROVIDED BY OPERATING ACTIVITIES

     16,380,299        10,628,372   
  

 

 

   

 

 

 

Financing activities

    

Borrowings on debt

     9,000,000        10,600,000   

Paydowns on debt

     —          (20,200,000

Issuance of notes

     —          13,074,525   

Payments of deferred debt financing costs

     (644,845     (458,753

Repurchases of common stock

     (3,256,613     (38,981

Payments of cash dividends

     (5,222,112     (6,503,846
  

 

 

   

 

 

 

NET CASH USED IN FINANCING ACTIVITIES

     (123,570     (3,527,055
  

 

 

   

 

 

 

NET INCREASE IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS

     16,256,729        7,101,317   

CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD

     7,034,783        20,063,372   
  

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD

   $ 23,291,512      $ 27,164,689   
  

 

 

   

 

 

 

Supplemental information:

    

Interest paid during the period

   $ 6,784,922      $ 6,126,220   

Supplemental non-cash information:

    

Payment-in-kind interest income

   $ 433,609      $ 900,398   

Net accretion of discount on investments

   $ 408,557      $ 377,279   

Amortization of deferred debt financing costs

   $ 775,707      $ 669,831   

Stock dividend distribution

   $ 4,125,696      $ 3,778,630   

See accompanying notes to consolidated financial statements.

 

8


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

November 30, 2016

(unaudited)

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed-end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed the initial public offering (“IPO”) on March 28, 2007. The Company has elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). The Company expects to continue to qualify and to elect to be treated, for tax purposes, as a RIC. The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in connection with the consummation of a recapitalization transaction.

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to a management agreement (the “Management Agreement”). Prior to July 30, 2010, the Company was managed and advised by GSCP (NJ), L.P.

The Company has established wholly-owned subsidiaries, SIA Avionte, Inc., SIA GH, Inc., SIA Mercury, Inc., SIA TT, Inc., and SIA Vector, Inc., which are structured as Delaware entities, or tax blockers, to hold equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). Tax blockers are consolidated for accounting purposes, but are not consolidated for income tax purposes and may incur income tax expense as a result of their ownership of portfolio companies.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us will expire. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), are stated in U.S. Dollars and include the accounts of the Company and its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC). All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

 

9


Table of Contents

The Company and SBIC LP are both considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, “Financial Services — Investment Companies” (“ASC Topic 946”). There have been no changes to the Company or SBIC LP’s status as investment companies during the nine months ended November 30, 2016.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as a money market fund if such investment would cause the Company to exceed any of the following limitations:

 

    we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

    we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

 

    we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

As of November 30, 2016, the Company did not exceed any of these limitations.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within our wholly-owned subsidiary, SBIC LP.

In November 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”). ASU 2016-18 requires that the statements of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statements of cash flows. The new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, and early adoption is permitted and is to be applied on a retrospective basis. The Company has adopted the provisions of ASU 2016-18 as of November 30, 2016. The adoption of the provisions of ASU 2016-18 did not materially impact the Company’s consolidated financial position or results of operations. Prior period amounts were reclassified to conform to the current period presentation.

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:

 

10


Table of Contents
     November 30,
2016
     November 30,
2015
 

Cash and cash equivalents

   $ 5,770,230      $ 6,019,448   

Cash and cash equivalents, reserve accounts

     17,521,282         21,145,241   
  

 

 

    

 

 

 

Total cash and cash equivalents, and cash and cash equivalents, reserve accounts

   $ 23,291,512       $ 27,164,689   
  

 

 

    

 

 

 

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

 

    An independent valuation firm, engaged by our board of directors, reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year.

In addition, all our investments are subject to the following valuation process:

 

    The audit committee of our board of directors reviews and approves each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our

 

11


Table of Contents

board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO. Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Derivative Financial Instruments

We account for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40,  Investments-Other, Beneficial Interests in Securitized Financial Assets , (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in the consolidated statements of operations when earned.

Payment-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight line method over the life of the respective facility and debt securities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”) requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction

 

12


Table of Contents

from the carrying amount of that debt liability, consistent with debt discounts. The Company has adopted the provisions of ASU 2015-03 as of February 28, 2015, by reclassifying deferred debt financing costs from within total assets to within total liabilities as a contra-liability. Prior period amounts were reclassified to conform to the current period presentation.

Contingencies

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated, for tax purposes, as a RIC under the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable U.S. Treasury regulations and private letter rulings issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740,  Income Taxes , (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 29, 2016, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2013, 2014, 2015 and 2016 federal tax years for the Company remain subject to examination by the IRS. As of November 30, 2016 and February 29, 2016, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare a cash

 

13


Table of Contents

dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains, net of realized and unrealized losses for the period.

New Accounting Pronouncements

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which is intended to reduce the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for annual periods beginning after December 15, 2017, and interim periods therein. Early adoption is permitted. Management is currently evaluating the impact ASU 2016-15 will have on the Company’s consolidated financial statements and disclosures.

In February 2016, the FASB issued ASU 2016-02, Amendments to the Leases (“ASC Topic 842”), which will require for all operating leases the recognition of a right-of-use asset and a lease liability, in the statement of financial position. The lease cost will be allocated over the lease term on a straight-line basis. This guidance is effective for annual and interim periods beginning after December 15, 2018. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 retains many current requirements for the classification and measurement of financial instruments; however, it significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated with the fair value of financial instruments. This guidance is effective for annual and interim periods beginning after December 15, 2017, and early adoption is not permitted for public business entities. Management is currently evaluating the impact the adoption of this standard has on the Company’s consolidated financial statements and disclosures.

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management does not believe these changes will have a material impact on the Company’s consolidated financial statements and disclosures.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) , which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In May 2016, ASU 2016-12 amended ASU 2014-09 and deferred the effective period to December 15, 2017. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

 

14


Table of Contents

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

    Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

    Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

    Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by a disclaimer would result in classification as a Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of November 30, 2016 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Syndicated loans

   $ —        $ —        $ 9,627       $ 9,627   

First lien term loans

     —          —          160,460         160,460   

Second lien term loans

     —          —          80,195         80,195   

Structured finance securities

     —          —          15,266         15,266   

Equity interests

     —          —          12,022         12,022   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —        $ —        $ 277,570       $ 277,570   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

15


Table of Contents

The following table presents fair value measurements of investments, by major class, as of February 29, 2016 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Syndicated loans

   $ —        $ —        $ 11,868       $ 11,868   

First lien term loans

     —          —          144,643         144,643   

Second lien term loans

     —          —          88,178         88,178   

Structured finance securities

     —          —          12,828         12,828   

Equity interests

     —          —          26,479         26,479   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —        $ —        $ 283,996       $ 283,996   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2016 (dollars in thousands):

 

     Syndicated
loans
    First lien
term loans
    Second
lien
term loans
    Structured
finance
securities
    Common
stock/
equities
    Total  

Balance as of February 29, 2016

   $ 11,868      $ 144,643      $ 88,178      $ 12,828      $ 26,479      $ 283,996   

Net unrealized appreciation/(depreciation) on investments

     2,221        (174     290        20        (13,085     (10,728

Purchases and other adjustments to cost

     56        69,671        10,996        4,500        1,470        86,693   

Sales and repayments

     (4,571     (54,033     (19,500     (2,082     (14,505     (94,691

Net realized gain from investments

     53        353        231              11,663        12,300   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of November 30, 2016

   $ 9,627      $ 160,460      $ 80,195      $ 15,266      $ 12,022      $ 277,570   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:

            

Net change in unrealized gains (losses):

   $ 1,075      $ 204      $ (500   $ 20      $ (1,981   $ (1,182
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and repayments represent net proceeds received from investments sold, and principal paydowns received, during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur.

 

16


Table of Contents

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2015 (dollars in thousands):

 

     Syndicated
loans
    First lien
term loans
    Second
lien
term loans
    Unsecured
notes
    Structured
finance
securities
    Common
stock/
equities
    Total  

Balance as of February 28, 2015

   $ 18,302      $ 145,207      $ 35,603      $ 4,230      $ 17,031      $ 20,165      $ 240,538   

Net unrealized appreciation/(depreciation) on investments

     (1,442     (1,271     (67     656        1,030        1,333        239   

Purchases and other adjustments to cost

     30        30,254        27,341        669              413        58,707   

Sales and repayments

     (2,370     (28,657     (19,502     (5,917     (2,285     (3,946     (62,677

Net realized gain from investments

     18        106        186        261              3,660        4,231   

Restructures in

     —         —         —         101        —         —          101   

Restructures out

     —         —         —         —          —         (101     (101
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of November 30, 2015

   $ 14,538      $ 145,639      $ 43,561      $ —       $ 15,776      $ 21,524      $ 241,038   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:

              

Net change in unrealized gains (losses):

   $ (1,458   $ (1,270   $ (187   $ 92      $ 1,030      $ 1,577      $ (216
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and repayments represent net proceeds received from investments sold, and principal paydowns received, during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of November 30, 2016 were as follows (dollars in thousands):

 

     Fair Value      Valuation Technique    Unobservable Input    Range

Syndicated loans

   $ 9,627       Market Comparables    Third-Party Bid (%)    97.6%  - 99.9%

First lien term loans

     160,460       Market Comparables    Market Yield (%)    6.4%  - 16.4%
         EBITDA Multiples (x)    1.0x  - 6.8x
         Third-Party Bid (%)    96.0%  - 99.9%

Second lien term loans

     80,195       Market Comparables    Market Yield (%)    8.3%  - 15.0%
         Third-Party Bid (%)    94.0% - 102.0%

Structured finance securities

     15,266       Discounted Cash Flow    Discount Rate (%)    10.5%  - 15.0%

Equity interests

     12,022       Market Comparables    EBITDA Multiples (x)    2.9x  - 11.9x

 

17


Table of Contents

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 29, 2016 were as follows (dollars in thousands):

 

     Fair Value      Valuation Technique    Unobservable Input    Range

Syndicated loans

   $ 11,868       Market Comparables    Third-Party Bid (%)    72.5% - 98.2%

First lien term loans

     144,643       Market Comparables    Market Yield (%)    6.8% - 15.5%
         EBITDA Multiples (x)    1.0x
         Revenue Multiples (x)

Third-Party Bid (%)

   91.3% - 98.9%

Second lien term loans

     88,178       Market Comparables    Market Yield (%)    0.0% - 15.0%
         Third-Party Bid (%)    91.5% - 98.6%

Structured finance securities

     12,828       Discounted Cash Flow    Discount Rate (%)    20.0%

Equity interests

     26,479       Market Comparables    EBITDA Multiples (x)

Revenue Multiples (x)

   6.8x - 16.4x

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement. For investments utilizing a market quote in deriving a value, a significant increase (decrease) in the market quote, in isolation, would result in a significantly higher (lower) fair value measurement.

The composition of our investments as of November 30, 2016, at amortized cost and fair value was as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

   $ 9,677         3.4   $ 9,627         3.5

First lien term loans

     162,236         56.8        160,460         57.8   

Second lien term loans

     81,213         28.5        80,195         28.9   

Structured finance securities

     15,448         5.4        15,266         5.5   

Equity interests

     16,904         5.9        12,022         4.3   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 285,478         100.0   $ 277,570         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

The composition of our investments as of February 29, 2016, at amortized cost and fair value was as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

   $ 14,138         5.0   $ 11,868         4.2

First lien term loans

     146,246         52.0        144,643         50.9   

Second lien term loans

     89,486         31.9        88,178         31.1   

Structured finance securities

     13,031         4.6        12,828         4.5   

Equity interests

     18,275         6.5        26,479         9.3   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 281,176         100.0   $ 283,996         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

 

18


Table of Contents

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. For the quarter ended November 30, 2013, in connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on assumptions about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at November 30, 2016. The significant inputs for the valuation model include:

 

    Default rates: 2.0%

 

    Recovery rates: 35-70%

 

    Prepayment rate: 20.0%

 

    Reinvestment rate / price: L+375bps / $99.50

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30.0 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was initially refinanced in October 2013 and its reinvestment period ended in October 2016. On November 15, 2016, we completed the second refinancing of the Saratoga CLO. The Saratoga CLO refinancing, among other things, extended its reinvestment period to October 2018, and extended its legal maturity date to October 2025. Following the refinancing, the Saratoga CLO portfolio remained at the same size and with a similar capital structure of approximately $300.0 million in aggregate principal amount of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we also purchased $4.5 million in aggregate principal amount of the Class F notes tranche of the Saratoga CLO at par, with a coupon of LIBOR plus 8.5%.

The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. Following the refinancing, we receive a base management fee of 0.10% and a subordinated management fee of 0.40% of the fee basis amount at the beginning of the collection period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%. For the three months ended November 30, 2016 and November 30, 2015, we accrued $0.4 million and $0.4 million in management fee income, respectively, and $0.5 million and $0.8 million in interest income, respectively, from Saratoga CLO. For the nine months ended November 30, 2016 and November 30, 2015, we accrued $1.1 million and $1.1 million in management fee income, respectively, and $1.6 million and $2.0 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee from Saratoga CLO as the 12.0% hurdle rate has not yet been achieved.

At November 30, 2016, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $11.0 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At November 30, 2016, Saratoga CLO had investments with a principal balance of $297.5 million and a weighted average spread over LIBOR of 4.31%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 2.35%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other

 

19


Table of Contents

operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At November 30, 2016, the present value of the projected future cash flows of the subordinated notes was approximately $11.0 million, using an 15.0% discount rate. Saratoga Investment Corp. invested $32.8 million into the CLO since January 2008, and to date has since received distributions of $48.5 million and management fees of $16.1 million.

Below is certain financial information from the separate financial statements of Saratoga CLO as of November 30, 2016 (unaudited) and February 29, 2016 and for the three and nine months ended November 30, 2016 and November 30, 2015 (unaudited).

 

20


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

     As of  
     November 30, 2016     February 29, 2016  
     (unaudited)        

ASSETS

    

Investments

    

Fair Value Loans (amortized cost of $294,551,697 and $300,112,538, respectively)

   $ 289,961,397      $ 284,652,926   

Fair Value Other/Structured finance securities (amortized cost of $3,531,218 and $3,531,218, respectively)

     37,455        191,863   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $298,082,915 and $303,643,756, respectively)

     289,998,852        284,844,789   

Cash and cash equivalents

     16,002,200        2,349,633   

Receivable from open trades

     2,500        2,691,831   

Interest receivable

     1,734,794        1,698,562   
  

 

 

   

 

 

 

Total assets

   $ 307,738,346      $ 291,584,815   
  

 

 

   

 

 

 

LIABILITIES

    

Interest payable

   $ 883,263      $ 626,040   

Payable from open trades

     11,925,775        7,123,854   

Due to affiliate

     46,078        —     

Accrued base management fee

     65,471        85,008   

Accrued subordinated management fee

     105,504        85,008   

Class A-1 Notes - SIC CLO 2013-1, Ltd.

     170,000,000        170,000,000   

Discount on Class A-1 Notes - SIC CLO 2013-1, Ltd.

     —          (1,319,258

Class A-2 Notes - SIC CLO 2013-1, Ltd.

     20,000,000        20,000,000   

Discount on Class A-2 Notes - SIC CLO 2013-1, Ltd.

     —          (136,750

Class B Notes - SIC CLO 2013-1, Ltd.

     44,800,000        44,800,000   

Discount on Class B Notes - SIC CLO 2013-1, Ltd.

     —          (888,328

Class C Notes - SIC CLO 2013-1, Ltd.

     16,000,000        16,000,000   

Discount on Class C Notes - SIC CLO 2013-1, Ltd.

     (79,605     (553,078

Class D Notes - SIC CLO 2013-1, Ltd.

     14,000,000        14,000,000   

Discount on Class D Notes - SIC CLO 2013-1, Ltd.

     (369,566     (717,938

Class E Notes - SIC CLO 2013-1, Ltd.

     13,100,000        13,100,000   

Discount on Class E Notes - SIC CLO 2013-1, Ltd.

     —          (1,353,521

Class F Notes - SIC CLO 2013-1, Ltd.

     4,500,000        4,500,000   

Discount on Class F Notes - SIC CLO 2013-1, Ltd.

     —          (492,300

Deferred debt financing costs, SIC CLO 2013-1, Ltd. Notes

     (973,665     (1,716,554

Subordinated Notes

     30,000,000        30,000,000   
  

 

 

   

 

 

 

Total liabilities

   $ 324,003,255      $ 313,142,183   
  

 

 

   

 

 

 

Commitments and contingencies

    

NET ASSETS

    

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

   $ 250      $ 250   

Accumulated loss

     (21,557,623     (5,803,406

Net gain (loss)

     5,292,464        (15,754,212
  

 

 

   

 

 

 

Total net assets

     (16,264,909     (21,557,368
  

 

 

   

 

 

 

Total liabilities and net assets

   $   307,738,346      $   291,584,815   
  

 

 

   

 

 

 

 

21


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

 

     For the three months ended
November 30
    For the nine months ended
November 30
 
     2016     2015     2016     2015  

INVESTMENT INCOME

        

Interest from investments

   $ 4,006,052      $ 3,559,889      $ 11,823,053      $ 10,711,063   

Interest from cash and cash equivalents

     3,095        158        5,804        663   

Other income

     82,239        14,064        515,376        248,057   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

     4,091,386        3,574,111        12,344,233        10,959,783   
  

 

 

   

 

 

   

 

 

   

 

 

 

EXPENSES

        

Interest expense

     2,457,705        2,912,974        9,347,508        8,772,617   

Professional fees

     39,694        66,203        79,120        178,602   

Miscellaneous fee expense

     25,974        9,758        48,365        20,446   

Base management fee

     167,592        184,694        541,763        560,643   

Subordinated management fee

     207,625        184,694        581,796        560,643   

Trustee expenses

     30,871        26,528        95,398        94,549   

Amortization expense

     302,635        237,966        782,561        717,892   

Loss on extinguishment of debt

     6,641,915        —          6,641,915        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     9,874,011        3,622,817        18,118,426        10,905,392   
  

 

 

   

 

 

   

 

 

   

 

 

 

NET INVESTMENT INCOME (LOSS)

     (5,782,625     (48,706     (5,774,193     54,391   
  

 

 

   

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

        

Net realized gain on investments

     130,337        217,472        351,753        349,117   

Net unrealized appreciation (depreciation) on investments

     926,507        (6,609,496     10,714,904        (10,319,542
  

 

 

   

 

 

   

 

 

   

 

 

 

Net gain (loss) on investments

     1,056,844        (6,392,024     11,066,657        (9,970,425
  

 

 

   

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

   $ (4,725,781   $ (6,440,730   $ 5,292,464      $ (9,916,034
  

 

 

   

 

 

   

 

 

   

 

 

 

 

22


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

November 30, 2016

(unaudited)

 

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Spread     LIBOR
Floor
    PIK     Current
Rate
(All In)
    Maturity
Date
    Principal /
Number of
Shares
    Cost     Fair Value  

Education Management II, LLC

  Leisure Goods/Activities/Movies   A-1 Preferred Shares   Equity     0.00     0.00     0.00     0.00       6,692      $ 669,214      $ 13,384   

Education Management II, LLC

  Leisure Goods/Activities/Movies   A-2 Preferred Shares   Equity     0.00     0.00     0.00     0.00       18,975        1,897,538        —     

New Millennium Holdco, Inc.

  Healthcare & Pharmaceuticals   Common Stock   Equity     0.00     0.00     0.00     0.00       14,813        964,466        24,071   

24 Hour Holdings III, LLC

  Leisure Goods/Activities/Movies   Term Loan   Loan     3.75     1.00     0.00     4.75     5/28/2021      $ 488,750        485,341        473,477   

ABB Con-Cise Optical Group, LLC

  Healthcare & Pharmaceuticals   Term Loan B   Loan     5.00     1.00     0.00     6.00     5/28/2021      $ 2,000,000        1,998,314        2,012,500   

Acosta Holdco, Inc.

  Media   Term Loan B1   Loan     3.25     1.00     0.00     4.25     9/26/2021      $ 1,960,150        1,948,749        1,853,577   

Aspen Dental Management, Inc.

  Healthcare & Pharmaceuticals   Term Loan Initial   Loan     4.25     1.00     0.00     5.25     4/29/2022      $ 1,488,710        1,484,608        1,497,092   

Advantage Sales & Marketing, Inc.

  Services: Business   Delayed Draw Term Loan   Loan     3.25     1.00     0.00     4.25     7/25/2021      $ 2,452,462        2,449,784        2,432,033   

Aegis Toxicology Science Corporation

  Healthcare & Pharmaceuticals   Term B Loan   Loan     4.50     1.00     0.00     5.50     2/24/2021      $ 2,469,866        2,336,816        2,290,801   

Agrofresh, Inc.

  Food Services   Term Loan   Loan     4.75     1.00     0.00     5.75     7/30/2021      $ 1,975,000        1,966,724        1,866,375   

Akorn, Inc.

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.25     1.00     0.00     5.25     4/16/2021      $ 398,056        396,882        401,042   

Albertson’s LLC

  Retailers (Except Food and Drugs)   Term Loan B-4   Loan     3.50     1.00     0.00     4.50     8/25/2021      $ 2,896,193        2,886,672        2,897,641   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare & Pharmaceuticals   Term Loan B   Loan     3.25     1.00     0.00     4.25     6/20/2022      $ 920,276        918,381        909,923   

Alion Science and Technology Corporation

  High Tech Industries   Term Loan B (First Lien)   Loan     4.50     1.00     0.00     5.50     8/19/2021      $ 2,962,500        2,950,476        2,899,547   

Alliance Healthcare Services, Inc.

  Healthcare & Pharmaceuticals   Term Loan B   Loan     3.25     1.00     0.00     4.25     6/3/2019      $ 987,141        983,080        962,462   

Anchor Glass T/L (11/16)

  Containers/Glass Products   Term Loan   Loan     3.25     1.00     0.00     4.25     11/22/2023      $ 500,000        497,511        502,190   

APCO Holdings, Inc.

  Automotive   Term Loan   Loan     6.00     1.00     0.00     7.00     1/31/2022      $ 1,966,351        1,916,134        1,917,192   

American Beacon Advisors, Inc.

  Financial Intermediaries   Term Loan (First Lien)   Loan     4.25     1.00     0.00     5.25     4/30/2022      $ 241,440        240,465        240,762   

Aramark Corporation

  Food Products   U.S. Term F Loan   Loan     2.50     0.75     0.00     3.25     2/24/2021      $ 3,126,374        3,126,374        3,149,822   

Astoria Energy T/L B

  Utilities   Term Loan   Loan     4.00     1.00     0.00     5.00     12/24/2021      $ 1,500,000        1,493,873        1,473,750   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Incremental Tranche B-1 Term Loan   Loan     3.75     1.25     0.00     5.00     5/24/2019      $ 531,422        527,619        533,915   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Term Loan B4 (First Lien)   Loan     4.00     1.00     0.00     5.00     8/4/2022      $ 2,440,625        2,430,001        2,454,048   

Auction.com, LLC

  Banking, Finance, Insurance & Real Estate   Term Loan   Loan     5.00     1.00     0.00     6.00     5/13/2019      $ 2,725,552        2,725,288        2,725,552   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics   Term Loan   Loan     5.00     1.00     0.00     6.00     6/21/2022      $ 2,791,407        2,767,475        2,807,681   

Bass Pro Group, LLC

  Retailers (Except Food and Drugs)   Term Loan   Loan     3.25     0.75     0.00     4.00     6/5/2020      $ 1,477,500        1,477,457        1,465,104   

Belmond Interfin Ltd.

  Lodging & Casinos   Term Loan   Loan     3.00     1.00     0.00     4.00     3/19/2021      $ 2,487,500        2,490,779        2,478,172   

BJ’s Wholesale Club, Inc.

  Food/Drug Retailers   New 2013 (November) Replacement Loan (First Lien)   Loan     3.50     1.00     0.00     4.50     9/26/2019      $ 2,432,199        2,434,086        2,434,996   

Blackboard T/L B4

  High Tech Industries   Term Loan B4   Loan     5.00     1.00     0.00     6.00     6/30/2021      $ 3,000,000        2,975,510        2,975,640   

BMC Software

  Technology   Term Loan   Loan     4.00     1.00     0.00     5.00     9/10/2020      $ 1,964,646        1,919,231        1,917,495   

BMC Software T/L US

  Technology   Term Loan   Loan     4.00     1.00     0.00     5.00     9/10/2020      $ 678,000        666,468        661,335   

Brickman Group Holdings, Inc.

  Brokers/Dealers/Investment Houses   Initial Term Loan (First Lien)   Loan     3.00     1.00     0.00     4.00     12/18/2020      $ 1,464,943        1,454,843        1,464,254   

BWAY Holding Company

  Leisure Goods/Activities/Movies   Term Loan B   Loan     4.50     1.00     0.00     5.50     8/14/2020      $ 942,307        935,335        944,267   

Camp International Holding Company

  Aerospace and Defense   2013 Replacement Term Loan (First Lien)   Loan     3.75     1.00     0.00     4.75     5/31/2019      $ 1,930,150        1,930,627        1,928,954   

Candy Intermediate Holdings, Inc.

  Beverage, Food & Tobacco   Term Loan   Loan     4.50     1.00     0.00     5.50     6/15/2023      $ 498,750        496,429        498,750   

Capital Automotive L.P.

  Conglomerate   Tranche B-1 Term Loan Facility   Loan     3.00     1.00     0.00     4.00     4/10/2019      $ 1,491,216        1,493,090        1,501,282   

Catalent Pharma Solutions, Inc

  Drugs   Initial Term B Loan   Loan     3.25     1.00     0.00     4.25     5/20/2021      $ 488,752        487,090        489,885   

Cengage Learning Acquisitions, Inc.

  Publishing   Term Loan   Loan     4.25     1.00     0.00     5.25     6/7/2023      $ 1,496,250        1,495,685        1,433,033   

Charter Communications Operating, LLC

  Cable and Satellite Television   Term F Loan   Loan     2.25     0.75     0.00     3.00     12/31/2020      $ 1,613,703        1,609,776        1,616,624   

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals   Term G Loan   Loan     2.75     1.00     0.00     3.75     12/31/2019      $ 1,014,862        992,398        959,683   

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals   Term H Loan   Loan     3.00     1.00     0.00     4.00     1/27/2021      $ 1,867,318        1,822,085        1,763,458   

CITGO Petroleum Corporation

  Oil & Gas   Term Loan B   Loan     3.50     1.00     0.00     4.50     7/29/2021      $ 1,969,899        1,950,189        1,964,974   

Communications Sales & Leasing, Inc.

  Telecommunications   Term Loan B (First Lien)   Loan     3.50     1.00     0.00     4.50     10/24/2022      $ 1,975,000        1,964,807        1,984,381   

Consolidated Aerospace Manufacturing, LLC

  Aerospace and Defense   Term Loan (First Lien)   Loan     3.75     1.00     0.00     4.75     8/11/2022      $ 1,437,500        1,431,231        1,322,500   

Concordia Healthcare Corporation

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.25     1.00     0.00     5.25     10/21/2021      $ 1,985,000        1,892,204        1,660,175   

CPI Acquisition Inc.

  Technology   Term Loan B (First Lien)   Loan     4.50     1.00     0.00     5.50     8/17/2022      $ 1,436,782        1,418,072        1,303,879   

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric   Term B Loan   Loan     3.25     1.00     0.00     4.25     11/17/2017      $ 2,552,242        2,551,083        2,533,100   

Crosby US Acquisition Corporation

  Industrial Equipment   Initial Term Loan (First Lien)   Loan     3.00     1.00     0.00     4.00     11/23/2020      $ 729,375        728,747        616,322   

CT Technologies Intermediate Hldgs, Inc

  Healthcare & Pharmaceuticals   Term Loan   Loan     4.25     1.00     0.00     5.25     12/1/2021      $ 1,473,844        1,462,088        1,414,890   

Culligan International Company-T/L

  Conglomerate   Term Loan   Loan     4.00     1.00     0.00     5.00     11/17/2023      $ 2,005,000        2,004,975        2,006,263   

Culligan International Company

  Conglomerate   Dollar Loan (First Lien)   Loan     4.75     1.50     0.00     6.25     12/19/2017      $ 3,757,779        3,716,494        3,738,990   

Culligan International Company

  Conglomerate   Dollar Loan (Second Lien)   Loan     8.00     1.50     0.00     9.50     6/19/2018      $ 783,162        762,650        780,225   

Cumulus Media Holdings Inc.

  Broadcast Radio and Television   Term Loan   Loan     3.25     1.00     0.00     4.25     12/23/2020      $ 470,093        467,173        283,231   

DAE Aviation (StandardAero)

  Aerospace and Defense   Term Loan   Loan     4.25     1.00     0.00     5.25     7/7/2022      $ 1,980,000        1,971,835        1,980,495   

DCS Business Services, Inc.

  Financial Intermediaries   Term B Loan   Loan     7.25     1.50     0.00     8.75     3/19/2018      $ 2,109,675        2,102,627        2,109,675   

Delta 2 (Lux) S.a.r.l.

  Lodging & Casinos   Term Loan B-3   Loan     3.75     1.00     0.00     4.75     7/30/2021      $ 1,000,000        996,370        1,005,000   

Deluxe Entertainment Service Group, Inc.

  Leisure Goods/Activities/Movies   Term Loan (Incremental)   Loan     6.00     1.00     0.00     7.00     2/28/2020      $ 1,000,000        970,592        971,250   

Deluxe Entertainment Service Group, Inc.

  Leisure Goods/Activities/Movies   Term Loan (First Lien)   Loan     5.50     1.00     0.00     6.50     2/28/2020      $ 1,880,622        1,881,696        1,837,518   

Diebold, Inc.

  High Tech Industries   Term Loan B   Loan     4.50     0.75     0.00     5.25     11/6/2023      $ 400,000        396,246        403,668   

DJO Finance, LLC

  Healthcare & Pharmaceuticals   Term Loan   Loan     3.25     1.00     0.00     4.25     6/8/2020      $ 493,750        492,061        472,766   

DPX Holdings B.V.

  Healthcare & Pharmaceuticals   Term Loan 2015 Incr Dollar   Loan     3.25     1.00     0.00     4.25     3/11/2021      $ 2,932,500        2,927,036        2,936,166   

Drew Marine Group, Inc.

  Chemicals/Plastics   Term Loan (First Lien)   Loan     3.25     1.00     0.00     4.25     11/19/2020      $ 2,956,135        2,927,349        2,882,232   

DTZ U.S. Borrower, LLC

  Construction & Building   Term Loan B Add-on   Loan     3.25     1.00     0.00     4.25     11/4/2021      $ 1,967,538        1,959,096        1,957,700   

Edelman Financial Group, Inc.

  Banking, Finance, Insurance & Real Estate   Term Loan   Loan     5.50     1.00     0.00     6.50     12/19/2022      $ 1,488,750        1,462,163        1,489,986   

Education Management II, LLC

  Leisure Goods/Activities/Movies   Term Loan A   Loan     4.50     1.00     0.00     5.50     7/2/2020      $ 501,970        487,866        115,453   

Education Management II, LLC

  Leisure Goods/Activities/Movies   Term Loan B (2.00% Cash/6.50% PIK)   Loan     1.00     1.00     6.50     8.50     7/2/2020      $ 938,381        916,819        35,968   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan (First Lien)   Loan     3.50     1.00     0.00     4.50     8/1/2021      $ 480,909        479,214        482,712   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan (Second Lien)   Loan     6.75     1.00     0.00     7.75     8/1/2022      $ 500,000        498,071        497,710   

Emerald 2 Limited

  Chemicals/Plastics   Term Loan B1A   Loan     4.00     1.00     0.00     5.00     5/14/2021      $ 1,000,000        993,485        925,000   

Endo International plc

  Healthcare & Pharmaceuticals   Term Loan B   Loan     3.00     0.75     0.00     3.75     9/26/2022      $ 992,500        990,394        984,749   

EnergySolutions, LLC

  Environmental Industries   Term Loan B   Loan     5.75     1.00     0.00     6.75     5/29/2020      $ 795,000        784,985        800,963   

Engility Corporation

  Aerospace and Defense   Term Loan B-1   Loan     4.25     0.70     0.00     4.95     8/12/2020      $ 250,000        248,811        251,770   

Evergreen Acqco 1 LP

  Retailers (Except Food and Drugs)   New Term Loan   Loan     3.75     1.25     0.00     5.00     7/9/2019      $ 957,600        956,486        886,383   

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment   Term Loan (First Lien)   Loan     3.75     1.00     0.00     4.75     1/15/2021      $ 1,952,349        1,948,532        1,954,789   

EWT Holdings III Corp.

  Capital Equipment   Term Loan   Loan     4.50     1.00     0.00     5.50     1/15/2021      $ 995,000        986,153        996,662   

Extreme Reach, Inc.

  Media   Term Loan B   Loan     6.25     1.00     0.00     7.25     2/7/2020      $ 2,943,750        2,914,312        2,969,508   

Federal-Mogul Corporation

  Automotive   Tranche C Term Loan   Loan     3.75     1.00     0.00     4.75     4/15/2021      $ 2,932,500        2,922,802        2,841,270   

First Data Corporation

  Financial Intermediaries   First Data T/L Ext (2021)   Loan     3.00     0.70     0.00     3.70     3/24/2021      $ 1,909,673        1,821,389        1,917,140   

First Eagle Investment Management

  Banking, Finance, Insurance & Real Estate   Term Loan   Loan     4.00     0.75     0.00     4.75     12/1/2022      $ 1,488,750        1,462,691        1,493,871   

Fitness International, LLC

  Leisure Goods/Activities/Movies   Term Loan B   Loan     5.00     1.00     0.00     6.00     7/1/2020      $ 1,934,146        1,908,664        1,934,146   

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

  Nonferrous Metals/Minerals   Loan   Loan     2.75     1.00     0.00     3.75     6/28/2019      $ 1,207,069        1,208,510        1,207,371   

Garda World Security Corporation

  Services: Business   Term B Delayed Draw Loan   Loan     3.00     1.00     0.00     4.00     11/6/2020      $ 197,592        196,978        194,012   

Garda World Security Corporation

  Services: Business   Term B Loan   Loan     3.00     1.00     0.00     4.00     11/6/2020      $ 772,408        770,060        758,411   

Gardner Denver, Inc.

  High Tech Industries   Initial Dollar Term Loan   Loan     3.25     1.00     0.00     4.25     7/30/2020      $ 2,432,330        2,427,218        2,363,009   

Gates Global LLC

  Leisure Goods/Activities/Movies   Term Loan (First Lien)   Loan     3.25     1.00     0.00     4.25     7/5/2021      $ 482,906        478,077        480,139   

General Nutrition Centers, Inc.

  Retailers (Except Food and Drugs)   Amended Tranche B Term Loan   Loan     2.50     0.75     0.00     3.25     3/4/2019      $ 2,123,160        2,119,206        2,025,856   

Global Tel*Link Corporation

  Services: Business   Term Loan (First Lien)   Loan     3.75     1.25     0.00     5.00     5/26/2020      $ 2,675,183        2,668,213        2,635,884   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics   Loan (Second Lien)   Loan     3.00     0.75     0.00     3.75     4/30/2019      $ 2,000,000        1,978,530        2,013,500   

Grosvenor Capital Management Holdings, LP

  Brokers/Dealers/Investment Houses   Initial Term Loan   Loan     2.75     1.00     0.00     3.75     1/4/2021      $ 1,014,560        1,011,388        1,006,109   

GTCR Valor Companies, Inc.

  Services: Business   Term Loan B   Loan     6.00     1.00     0.00     7.00     5/17/2023      $ 1,496,250        1,438,257        1,442,954   

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing   Tranche B-4 Term Loan   Loan     5.99     1.00     0.00     6.99     8/2/2019      $ 2,452,292        2,359,268        2,439,000   

Headwaters Incorporated

  Building & Development   Term Loan   Loan     3.00     1.00     0.00     4.00     3/24/2022      $ 246,875        245,872        247,904   

Help/Systems Holdings, Inc.

  High Tech Industries   Term Loan   Loan     5.25     1.00     0.00     6.25     10/8/2021      $ 1,488,750        1,435,008        1,476,349   

Hemisphere Media Holdings, LLC

  Media   Term Loan B   Loan     4.00     1.00     0.00     5.00     7/30/2020      $ 2,500,000        2,511,306        2,493,750   

Hercules Achievement Holdings, Inc.

  Retailers (Except Food and Drugs)   Term Loan B   Loan     4.00     1.00     0.00     5.00     12/10/2021      $ 247,481        245,345        249,585   

Hoffmaster Group, Inc.

  Containers/Glass Products   Term Loan   Loan     4.50     1.00     0.00     5.50     11/10/2023      $ 1,000,000        1,003,750        999,380   

Hostess Brand, LLC

  Beverage, Food & Tobacco   Term Loan B (First Lien)   Loan     3.00     1.00     0.00     4.00     8/3/2022      $ 1,490,000        1,486,283        1,497,823   

Huntsman International LLC

  Chemicals/Plastics   Term Loan B (First Lien)   Loan     3.00     0.70     0.00     3.70     4/19/2019      $ 2,809,046        2,793,042        2,813,260   

Husky Injection Molding Systems Ltd.

  Services: Business   Term Loan B   Loan     3.25     1.00     0.00     4.25     6/30/2021      $ 487,465        485,699        486,490   

Hyperion Refinance T/L

  Banking, Finance, Insurance & Real Estate   Term Loan   Loan     4.50     1.00     0.00     5.50     4/29/2022      $ 2,000,000        1,982,160        1,982,500   

Imagine! Print Solutions, Inc.

  Media   Term Loan B   Loan     6.00     1.00     0.00     7.00     3/30/2022      $ 497,500        490,794        500,923   

Infor (US), Inc. (fka Lawson Software Inc.)

  Services: Business   Tranche B-5 Term Loan   Loan     2.75     1.00     0.00     3.75     6/3/2020      $ 2,134,125        2,122,744        2,129,686   

Insight Global

  Services: Business   Term Loan   Loan     5.00     1.00     0.00     6.00     10/29/2021      $ 3,459,111        3,442,956        3,473,536   

Informatica Corporation

  High Tech Industries   Term Loan B   Loan     3.50     1.00     0.00     4.50     8/5/2022      $ 495,000        493,929        483,556   

J. Crew Group, Inc.

  Retailers (Except Food and Drugs)   Term B-1 Loan Retired 03/05/2014   Loan     3.00     1.00     0.00     4.00     3/5/2021      $ 948,188        948,188        606,840   

Jazz Acquisition, Inc

  Aerospace and Defense   First Lien 6/14   Loan     3.50     1.00     0.00     4.50     6/19/2021      $ 489,091        488,214        453,940   

J.Jill Group, Inc.

  Retailers (Except Food and Drugs)   Term Loan (First Lien)   Loan     5.00     1.00     0.00     6.00     5/9/2022      $ 987,505        983,403        965,286   

Kinetic Concepts, Inc.

  Healthcare & Pharmaceuticals   Term Loan F-1   Loan     4.00     1.00     0.00     5.00     11/4/2020      $ 2,434,098        2,409,562        2,390,284   

Koosharem, LLC

  Services: Business   Term Loan   Loan     6.50     1.00     0.00     7.50     5/15/2020      $ 2,942,588        2,923,892        2,648,329   

Kraton Polymers, LLC

  Chemicals/Plastics   Term Loan (Initial)   Loan     5.00     1.00     0.00     6.00     1/6/2022      $ 2,500,000        2,277,562        2,513,675   

Lannett Company, Inc.

  Healthcare & Pharmaceuticals   Term Loan B   Loan     5.38     1.00     0.00     6.38     11/25/2022      $ 1,925,000        1,865,075        1,872,063   

Learfield Communications Initial T/L (A-L Parent)

  Healthcare & Pharmaceuticals   Initial Term Loan (A-L Parent)   Loan     3.25     1.00     0.00     4.25     11/17/2023      $ 500,000        497,500        501,250   

LPL Holdings

  Banking, Finance, Insurance & Real Estate   Term Loan B (2022)   Loan     4.00     0.75     0.00     4.75     11/21/2022      $ 1,985,000        1,967,639        1,999,054   

McGraw-Hill Global Education Holdings, LLC

  Publishing   Term Loan   Loan     4.00     1.00     0.00     5.00     5/4/2022      $ 997,500        993,085        987,884   

Mauser Holdings, Inc.

  Containers/Glass Products   Term Loan   Loan     3.50     1.00     0.00     4.50     7/31/2021      $ 490,000        488,278        491,838   

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)   Term Loan B1   Loan     2.75     1.00     0.00     3.75     1/30/2023      $ 1,684,412        1,678,497        1,696,000   

Micro Holding Corporation

  High Tech Industries   Term Loan   Loan     3.75     1.00     0.00     4.75     7/8/2021      $ 985,413        981,373        988,803   

Microsemi Corporation

  Electronics/Electric   Term Loan B   Loan     3.00     0.75     0.00     3.75     1/17/2023      $ 892,985        868,970        897,950   

Midas Intermediate Holdco II, LLC

  Automotive   Term Loan (Initial)   Loan     3.50     1.00     0.00     4.50     8/18/2021      $ 245,000        244,071        245,919   

Milk Specialties Company

  Beverage, Food & Tobacco   Term Loan   Loan     5.00     1.00     0.00     6.00     8/16/2023      $ 1,000,000        990,342        1,008,750   

MSC Software Corporation

  Services: Business   Term Loan   Loan     4.00     1.00     0.00     5.00     5/29/2020      $ 1,974,949        1,934,256        1,970,012   

MWI Holdings, Inc.

  Capital Equipment   Term Loan (First Lien)   Loan     5.50     1.00     0.00     6.50     6/29/2020      $ 2,992,500        2,986,899        2,992,500   

National Veterinary Associates, Inc

  Healthcare & Pharmaceuticals   Term Loan B   Loan     3.75     1.00     0.00     4.75     8/14/2021      $ 980,038        977,191        981,675   

National Vision, Inc.

  Retailers (Except Food and Drugs)   Term Loan (Second Lien)   Loan     5.75     1.00     0.00     6.75     3/11/2022      $ 250,000        249,780        238,437   

New Media Holdings II T/L (NEW)

  Retailers (Except Food and Drugs)   Term Loan   Loan     6.25     1.00     0.00     7.25     6/4/2020      $ 2,674,923        2,662,001        2,644,830   

New Millennium Holdco, Inc.

  Healthcare & Pharmaceuticals   Term Loan   Loan     6.50     1.00     0.00     7.50     12/21/2020      $ 1,935,123        1,771,899        1,154,630   

NorthStar Asset Management Group, Inc.

  Banking, Finance, Insurance & Real Estate   Term Loan B   Loan     3.88     0.75     0.00     4.63     1/30/2023      $ 1,990,000        1,926,727        1,988,348   

Novelis, Inc.

  Conglomerate   Term Loan B   Loan     3.25     0.75     0.00     4.00     6/2/2022      $ 4,735,095        4,715,782        4,740,256   

Novetta Solutions

  Aerospace and Defense   Term Loan (200MM)   Loan     5.00     1.00     0.00     6.00     10/16/2022      $ 1,985,000        1,967,682        1,890,712   

Novetta Solutions

  Aerospace and Defense   Term Loan (2nd Lien)   Loan     8.50     1.00     0.00     9.50     9/29/2023      $ 1,000,000        990,986        930,000   

NPC International, Inc.

  Food Services   Term Loan (2013)   Loan     3.75     1.00     0.00     4.75     12/28/2018      $ 477,298        477,298        477,598   

NVA Holdings, Inc.

  Services: Consumer   Term Loan B1   Loan     4.50     1.00     0.00     5.50     8/14/2021      $ 157,841        157,485        158,236   

NXT Capital T/L (11/16)

  Banking, Finance, Insurance & Real Estate   Term Loan   Loan     4.50     1.00     0.00     5.50     11/23/2022      $ 1,000,000        995,000        1,000,000   

Om Group

  Banking, Finance, Insurance & Real Estate   Term Loan   Loan     6.00     1.00     0.00     7.00     10/28/2021      $ 994,987        903,045        991,883   

ON Semiconductor Corporation

  High Tech Industries   Term Loan B   Loan     3.25     0.70     0.00     3.95     3/31/2023      $ 500,000        499,320        502,500   

Onex Carestream Finance LP

  Healthcare & Pharmaceuticals   Term Loan (First Lien 2013)   Loan     4.00     1.00     0.00     5.00     6/7/2019      $ 3,668,306        3,659,647        3,232,695   

OnexYork Acquisition Co

  Healthcare & Pharmaceuticals   Term Loan B   Loan     3.75     1.00     0.00     4.75     10/1/2021      $ 490,000        487,264        452,637   

OpenLink International, LLC

  Services: Business   Term B Loan   Loan     6.50     1.25     0.00     7.75     7/29/2019      $ 2,921,492        2,920,807        2,947,055   

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers   Term Borrowing   Loan     3.25     1.00     0.00     4.25     6/24/2019      $ 1,421,386        1,417,039        1,400,065   

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

  Services: Business   Term Loan (First Lien)   Loan     4.00     1.00     0.00     5.00     10/30/2020      $ 972,500        969,216        914,150   

Petsmart, Inc. (Argos Merger Sub, Inc.)

  Retailers (Except Food and Drugs)   Term Loan B1   Loan     3.00     1.00     0.00     4.00     3/11/2022      $ 985,000        980,220        987,728   

PGX Holdings, Inc.

  Financial Intermediaries   Term Loan   Loan     4.75     1.00     0.00     5.75     9/29/2020      $ 911,429        905,316        911,046   

Planet Fitness Holdings LLC

  Leisure Goods/Activities/Movies   Term Loan   Loan     3.50     0.75     0.00     4.25     3/31/2021      $ 2,398,337        2,390,948        2,392,341   

Polycom Term Loan (9/16)

  Telecommunications   Term Loan   Loan     6.50     1.00     0.00     7.50     9/27/2023      $ 2,000,000        1,972,500        1,966,260   

PrePaid Legal Services, Inc.

  Services: Business   Term Loan B   Loan     5.25     1.25     0.00     6.50     7/1/2019      $ 3,392,467        3,396,014        3,389,651   

Presidio, Inc.

  Services: Business   Term Loan   Loan     4.25     1.00     0.00     5.25     2/2/2022      $ 2,385,390        2,331,907        2,398,319   

Prime Security Services (Protection One)

  Services: Business   Term Loan   Loan     3.75     1.00     0.00     4.75     7/1/2021      $ 1,985,025        1,977,124        1,996,876   

Ranpak Holdings, Inc.

  Services: Business   Term Loan   Loan     3.25     1.00     0.00     4.25     10/1/2021      $ 931,264        928,935        923,115   

Ranpak Holdings, Inc.

  Services: Business   Term Loan (Second Lien)   Loan     7.25     1.00     0.00     8.25     10/3/2022      $ 500,000        498,073        470,000   

Redtop Acquisitions Limited

  Electronics/Electric   Initial Dollar Term Loan (First Lien)   Loan     3.50     1.00     0.00     4.50     12/3/2020      $ 486,259        484,109        485,044   

Regal Cinemas Corporation

  Services: Consumer   Term Loan   Loan     2.75     0.75     0.00     3.50     4/1/2022      $ 495,009        493,772        496,868   

Research Now Group, Inc

  Media   Term Loan B   Loan     4.50     1.00     0.00     5.50     3/18/2021      $ 2,042,890        2,034,414        1,981,603   

Rexnord LLC/RBS Global, Inc.

  Industrial Equipment   Term B Loan   Loan     3.00     1.00     0.00     4.00     8/21/2020      $ 1,540,540        1,541,627        1,544,607   

Reynolds Group Holdings Inc.

  Industrial Equipment   Incremental U.S. Term Loan   Loan     3.25     1.00     0.00     4.25     2/6/2023      $ 1,765,548        1,765,548        1,773,458   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche B-3 Term Loan   Loan     3.00     0.75     0.00     3.75     7/2/2021      $ 1,466,250        1,461,232        1,469,549   

Royal Adhesives and Sealants

  Chemicals/Plastics   Term Loan (First Lien)   Loan     3.50     1.00     0.00     4.50     6/20/2022      $ 493,750        491,669        496,219   

Royal Adhesives and Sealants

  Chemicals/Plastics   Term Loan (Second Lien)   Loan     7.50     1.00     0.00     8.50     6/19/2023      $ 500,000        496,621        493,750   

RPI Finance Trust

  Financial Intermediaries   Term B-4 Term Loan   Loan     2.50     0.70     0.00     3.20     10/14/2022      $ 2,561,167        2,561,167        2,581,758   

Russell Investment Management T/L B

  Banking, Finance, Insurance & Real Estate   Term Loan B   Loan     5.75     1.00     0.00     6.75     6/1/2023      $ 1,995,000        1,879,384        2,006,232   

Sable International Finance Ltd

  Telecommunications   Term Loan B1   Loan     4.75     0.75     0.00     5.50     12/2/2022      $ 825,000        809,615        831,922   

Sable International Finance Ltd

  Telecommunications   Term Loan B2   Loan     4.75     0.75     0.00     5.50     12/2/2022      $ 675,000        662,412        680,663   

SBP Holdings LP

  Industrial Equipment   Term Loan (First Lien)   Loan     4.00     1.00     0.00     5.00     3/27/2021      $ 975,000        971,747        819,000   

Scientific Games International, Inc.

  Electronics/Electric   Term Loan B2   Loan     5.00     1.00     0.00     6.00     10/1/2021      $ 982,500        973,672        990,684   

SCS Holdings (Sirius Computer)

  High Tech Industries   Term Loan (First Lien)   Loan     4.25     1.00     0.00     5.25     10/31/2022      $ 1,977,528        1,942,888        1,987,416   

Seadrill Operating LP

  Oil & Gas   Term Loan B   Loan     3.00     1.00     0.00     4.00     2/21/2021      $ 979,849        921,734        554,428   

Shearers Foods LLC

  Food Services   Term Loan (First Lien)   Loan     3.94     1.00     0.00     4.94     6/30/2021      $ 980,000        978,146        980,000   

Sitel Worldwide

  Telecommunications   Term Loan   Loan     5.50     1.00     0.00     6.50     9/18/2021      $ 1,980,000        1,963,403        1,968,239   

Sonneborn, LLC

  Chemicals/Plastics   Term Loan (First Lien)   Loan     3.75     1.00     0.00     4.75     12/10/2020      $ 208,512        208,136        208,860   

Sonneborn, LLC

  Chemicals/Plastics   Initial US Term Loan   Loan     3.75     1.00     0.00     4.75     12/10/2020      $ 1,181,569        1,179,439        1,183,542   

Sophia, L.P.

  Electronics/Electric   Term Loan (Closing Date)   Loan     3.75     1.00     0.00     4.75     9/30/2022      $ 1,965,897        1,957,501        1,967,136   

SourceHOV LLC

  Services: Business   Term Loan B (First Lien)   Loan     6.75     1.00     0.00     7.75     10/31/2019      $ 1,862,500        1,826,426        1,642,259   

SRAM, LLC

  Industrial Equipment   Term Loan (First Lien)   Loan     3.00     1.00     0.00     4.00     4/10/2020      $ 2,772,070        2,765,804        2,723,559   

Steak ‘n Shake Operations, Inc.

  Food Services   Term Loan   Loan     3.75     1.00     0.00     4.75     3/19/2021      $ 925,673        919,596        918,730   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing   Loan   Loan     8.60     3.00     0.00     11.60     12/30/2016      $ 200,478        200,472        77,685   

Survey Sampling International

  Services: Business   Term Loan B   Loan     5.00     1.00     0.00     6.00     12/16/2020      $ 2,728,677        2,713,545        2,715,033   

Sybil Finance BV

  High Tech Industries   Term Loan B   Loan     4.00     1.00     0.00     5.00     8/3/2022      $ 1,000,000        995,154        1,008,500   

Syniverse Holdings, Inc.

  Telecommunications   Initial Term Loan   Loan     3.00     1.00     0.00     4.00     4/23/2019      $ 468,977        466,744        416,386   

TaxACT, Inc.

  Services: Business   Term Loan B   Loan     6.00     1.00     0.00     7.00     1/3/2023      $ 1,350,000        1,313,620        1,353,375   

Tectum Holdings, Inc.

  Transportation   Delayed Draw Term Loan (Initial)   Loan     4.75     1.00     0.00     5.75     8/24/2023      $ 1,000,000        990,340        1,005,000   

TGI Friday’s, Inc.

  Food Services   Term Loan B   Loan     4.25     1.00     0.00     5.25     7/15/2020      $ 1,651,816        1,648,636        1,629,104   

Townsquare Media, Inc.

  Media   Term Loan B   Loan     3.25     1.00     0.00     4.25     4/1/2022      $ 932,522        928,849        932,522   

TPF II Power LLC and TPF II Covert Midco LLC

  Utilities   Term Loan B   Loan     4.00     1.00     0.00     5.00     10/2/2021      $ 1,413,873        1,362,183        1,420,235   

TransDigm, Inc.

  Aerospace and Defense   Tranche C Term Loan   Loan     3.00     0.75     0.00     3.75     2/28/2020      $ 4,244,222        4,249,544        4,249,952   

Travel Leaders Group, LLC

  Hotel, Gaming and Leisure   Term Loan B   Loan     6.00     1.00     0.00     7.00     12/7/2020      $ 2,629,084        2,615,196        2,603,898   

Trugreen Limited Partnership

  Services: Business   Term Loan B   Loan     5.50     1.00     0.00     6.50     4/13/2023      $ 498,750        491,925        502,491   

Twin River Management Group, Inc.

  Lodging & Casinos   Term Loan B   Loan     4.25     1.00     0.00     5.25     7/10/2020      $ 864,021        865,348        868,886   

Univar Inc.

  Chemicals/Plastics   Term B Loan   Loan     3.25     1.00     0.00     4.25     7/1/2022      $ 2,970,000        2,957,757        2,979,296   

Univision Communications Inc.

  Telecommunications   Replacement First-Lien Term Loan   Loan     3.00     1.00     0.00     4.00     3/1/2020      $ 2,893,389        2,883,224        2,892,347   

Valeant Pharmaceuticals International, Inc.

  Drugs   Series D2 Term Loan B   Loan     4.25     0.75     0.00     5.00     2/13/2019      $ 2,468,721        2,460,512        2,445,588   

Verint Systems Inc.

  Services: Business   Term Loan   Loan     2.75     0.75